Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 25(11)2024 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-38892469

RESUMEN

Mast cells take up extracellular latent heparanase and store it in secretory granules. The present study examined whether the enzymatic activity of heparanase regulates its uptake efficiency. Recombinant mouse heparanase mimicking both the latent and mature forms (L-Hpse and M-Hpse, respectively) was internalized into mastocytoma MST cells, peritoneal cell-derived mast cells, and bone marrow-derived mast cells. The internalized amount of L-Hpse was significantly higher than that of M-Hpse. In MST cells, L-Hpse was continuously internalized for up to 8 h, while the uptake of M-Hpse was saturated after 2 h of incubation. L-Hpse and M-Hpse are similarly bound to the MST cell surface. The expression level of cell surface heparan sulfate was reduced in MST cells incubated with M-Hpse. The internalized amount of M-Hpse into mast cells was significantly increased in the presence of heparastatin (SF4), a small molecule heparanase inhibitor that does not affect the binding of heparanase to immobilized heparin. Enzymatically quiescent M-Hpse was prepared with a point mutation at Glu335. The internalized amount of mutated M-Hpse was significantly higher than that of wild-type M-Hpse but similar to that of wild-type and mutated L-Hpse. These results suggest that the enzymatic activity of heparanase negatively regulates the mast cell-mediated uptake of heparanase, possibly via the downregulation of cell surface heparan sulfate expression.


Asunto(s)
Glucuronidasa , Heparitina Sulfato , Mastocitos , Mastocitos/metabolismo , Glucuronidasa/metabolismo , Glucuronidasa/genética , Animales , Heparitina Sulfato/metabolismo , Ratones , Línea Celular Tumoral
2.
Int J Mol Sci ; 23(9)2022 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-35563446

RESUMEN

We examined whether sulfated hyaluronan exerts inhibitory effects on enzymatic and biological actions of heparanase, a sole endo-beta-glucuronidase implicated in cancer malignancy and inflammation. Degradation of heparan sulfate by human and mouse heparanase was inhibited by sulfated hyaluronan. In particular, high-sulfated hyaluronan modified with approximately 2.5 sulfate groups per disaccharide unit effectively inhibited the enzymatic activity at a lower concentration than heparin. Human and mouse heparanase bound to immobilized sulfated hyaluronan. Invasion of heparanase-positive colon-26 cells and 4T1 cells under 3D culture conditions was significantly suppressed in the presence of high-sulfated hyaluronan. Heparanase-induced release of CCL2 from colon-26 cells was suppressed in the presence of sulfated hyaluronan via blocking of cell surface binding and subsequent intracellular NF-κB-dependent signaling. The inhibitory effect of sulfated hyaluronan is likely due to competitive binding to the heparanase molecule, which antagonizes the heparanase-substrate interaction. Fragment molecular orbital calculation revealed a strong binding of sulfated hyaluronan tetrasaccharide to the heparanase molecule based on electrostatic interactions, particularly characterized by interactions of (-1)- and (-2)-positioned sulfated sugar residues with basic amino acid residues composing the heparin-binding domain-1 of heparanase. These results propose a relevance for sulfated hyaluronan in the blocking of heparanase-mediated enzymatic and cellular actions.


Asunto(s)
Carcinoma , Glucuronidasa , Ácido Hialurónico , Animales , Carcinoma/tratamiento farmacológico , Carcinoma/metabolismo , Glucuronidasa/efectos de los fármacos , Glucuronidasa/metabolismo , Heparina/farmacología , Ácido Hialurónico/química , Ácido Hialurónico/farmacología , Ratones , Sulfatos
3.
Biochem Biophys Res Commun ; 520(1): 152-158, 2019 11 26.
Artículo en Inglés | MEDLINE | ID: mdl-31582210

RESUMEN

We examined whether chondroitin sulfates (CSs) exert inhibitory effects on heparanase (Hpse), the sole endoglycosidase that cleaves heparan sulfate (HS) and heparin, which also stimulates chemokine production. Hpse-mediated degradation of HS was suppressed in the presence of glycosaminoglycans derived from a squid cartilage and mouse bone marrow-derived mast cells, including the E unit of CS. Pretreatment of the chondroitin sulfate E (CS-E) with chondroitinase ABC abolished the inhibitory effect. Recombinant proteins that mimic pro-form and mature-form Hpse bound to the immobilized CS-E. Cellular responses as a result of Hpse-mediated binding, namely, uptake of Hpse by mast cells and Hpse-induced release of chemokine CCL2 from colon carcinoma cells, were also blocked by the CS-E. CS-E may regulate endogenous Hpse-mediated cellular functions by inhibiting enzymatic activity and binding to the cell surface.


Asunto(s)
Células de la Médula Ósea/metabolismo , Sulfatos de Condroitina/farmacología , Glucuronidasa/metabolismo , Animales , Células de la Médula Ósea/citología , Cartílago/metabolismo , Línea Celular , Línea Celular Tumoral , Membrana Celular/metabolismo , Quimiocinas/metabolismo , Colon/metabolismo , Neoplasias del Colon/metabolismo , Decapodiformes , Glicosaminoglicanos/metabolismo , Heparitina Sulfato/metabolismo , Humanos , Mastocitos/citología , Mastocitos/metabolismo , Ratones , Proteínas Recombinantes/farmacología
4.
Biochem Biophys Res Commun ; 499(3): 681-687, 2018 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-29608894

RESUMEN

We searched for inhibitors against prolyl isomerase Pin1 in order to develop functional foods to prevent and cure various Pin1 related diseases such as cancer, diabetes, cardiovascular disease, Alzheimers's disease, and so on. We created a polyphenol library consisting of ingredients in healthy foods and beverages, since polyphenols like epigallocatechin gallate (EGCG) in green tea and 974B in brown algae had been identified as its Pin1 inhibitors. Several polyphenols such as EGCG derivatives, caffeic acid derivatives and tannic acid inhibited Pin1 activity. These results provide a first step in development of the functional foods and beverage targeting Pin1 and its related diseases.


Asunto(s)
Alimentos , Peptidilprolil Isomerasa de Interacción con NIMA/antagonistas & inhibidores , Polifenoles/farmacología , Ácidos Cafeicos/química , Ácidos Cafeicos/farmacología , Catequina/química , Catequina/farmacología , Células HCT116 , Humanos , Peptidilprolil Isomerasa de Interacción con NIMA/metabolismo , Polifenoles/química , Quercetina/química , Quercetina/farmacología , Rutina/química , Rutina/farmacología , Taninos/química , Taninos/farmacología
5.
Biochem Biophys Res Commun ; 503(4): 3235-3241, 2018 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-30149916

RESUMEN

We investigated the fate of proheparanase added to the culture media of mast cells. A recombinant protein mimicking proheparanase was continuously internalized into mastocytoma cells as well as bone marrow- and peritoneal cell-derived mast cells. Internalized heparanase molecules were accumulated in granules and a significant portion was released by stimulation with ionomycin, indicating that the internalized heparanase was sorted into secretory granules. The pro-form heparanase was processed into a mature and an active form inside the cells, in which intracellular heparin was fragmented by the mature enzyme. The internalization was substantially inhibited by addition of heparin and heparan sulfate to the culture medium, suggesting that glycosaminoglycan is involved in the uptake pathway. Out of four syndecans, expression of syndecan-3 and syndecan-4, especially cell surface syndecan-4, was detected in the mastocytoma cells. Two knockdown clones transfected with a shRNA expression vector targeting the syndecan-4 gene took up significantly lower amounts of heparanase than mock cells. We propose that some exogenous substances like proheparanase can be incorporated into mast cell granules via a glycosaminoglycan-mediated, especially syndecan-4-dependent, uptake pathway.


Asunto(s)
Glucuronidasa/metabolismo , Mastocitos/fisiología , Sindecano-4/metabolismo , Animales , Degranulación de la Célula , Células Cultivadas , Endocitosis , Glicosaminoglicanos/metabolismo , Heparina/metabolismo , Heparitina Sulfato/metabolismo , Mastocitos/citología , Mastocitos/metabolismo , Ratones , Transporte de Proteínas , Proteínas Recombinantes/metabolismo , Transducción de Señal
6.
Biochim Biophys Acta ; 1861(12 Pt A): 2011-2019, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27720952

RESUMEN

Retinoic acid (RA) has a variety of biological effects in mammalian cells and tissues. It is well known that RA induces differentiation of human acute promyelocytic leukemia (APL) HL60 cells, fresh human APL cells, and clinical remission in patients with APL. Retinoylation (acylation of proteins by RA) is a possible pathway for RA action. However, an understanding of the role that retinoylation plays in the actions of RA is lacking. In the current study, several retinoylated proteins were detected in RA-treated HL60 fractions following Mono Q anion exchange chromatography and analysis using two-dimensional polyacrylamide gel electrophoresis. One of the retinoylated proteins was identified as Rho-GDIß (28kDa) by TOF-MS and co-migration with Rho-GDIß (28kDa). Truncated Rho-GDIß (23kDa, N∆19), a product of cleavage by caspase-3, was not retinoylated. RA covalently bound to the Thr2 residue in Rho-GDIß (5kDa), which is the second product resulting from the cleavage of Rho-GDIß (28kDa) by caspase-3. RA treatment increased the level of Rho-GDIß (28kDa) and decreased the level of Rho-GDIß (23kDa). RA did not induce caspase-3 activity or Rho-GDIß mRNA expression. It is likely that retinoylation of Rho-GDIß increases its metabolic stability.


Asunto(s)
Acilación/fisiología , Leucemia Mieloide/metabolismo , Tretinoina/farmacología , Inhibidor beta de Disociación del Nucleótido Guanina rho/metabolismo , Acilación/efectos de los fármacos , Secuencia de Aminoácidos , Caspasa 3/metabolismo , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Línea Celular Tumoral , Células HL-60 , Humanos , ARN/metabolismo , ARN Mensajero/metabolismo
7.
Biochim Biophys Acta Gen Subj ; 1861(2): 276-285, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27913186

RESUMEN

BACKGROUND: Activation of protein kinase A (PKA) occurs during retinoic acid (RA)-induced granulocytic differentiation of human promyelocytic leukemia HL60 cells. It is known that the RIIα regulatory subunit of PKA, is modified by RA (retinoylated) in the early stages of differentiation. We have investigated the effects of RA on PKA during cell differentiation in order to understand the potential significance of this process in the retinoylation of RIIα subunits. METHODS: Immunoblotting, immunoprecipitation, confocal microscopy, PCR, and PKA activity assays were employed for characterizing the effects of RA on PKA. RESULTS: We found that RA induces intracellular mobility of RIIα and the activation of PKA in HL60 cells. Increases in RIIα levels were observed in RA-treated HL60 cells. RA treatment altered intracellular localization of the PKA subunits, RIIα and Cα, and increased their protein levels in the nuclei as detected by both immunoblotting and immunostaining analyses. Coincident with the increase in nuclear Cα, RA-treated HL60 cells showed increases in both the protein phosphorylation activity of PKA and the levels of phosphorylated proteins in nuclear fractions as compared to control cells. In addition, RIIα protein was stabilized in RA-treated HL60 cells as compared to control cells. CONCLUSIONS: These results suggest that RA stabilizes RIIα protein and activates PKA in the nucleus, with a resultant increase in the phosphorylation of nuclear proteins. GENERAL SIGNIFICANCE: Our evidence suggests that retinoylation of PKA might contribute to its stabilization and activation and that this could potentially participate in RA's ability to induce granulocytic differentiation of HL60 cells.


Asunto(s)
Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Tretinoina/farmacología , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Células HL-60 , Humanos , Leucemia Promielocítica Aguda/tratamiento farmacológico , Leucemia Promielocítica Aguda/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas Nucleares/metabolismo , Fosforilación/efectos de los fármacos , Subunidades de Proteína/metabolismo , Transducción de Señal/efectos de los fármacos
8.
Biosci Biotechnol Biochem ; 81(9): 1687-1689, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28633601

RESUMEN

We report lectin microarray profile of the polysaccharide fraction derived from Sasa veitchii leaf that exhibits anti-influenza activity. This fraction showed higher reactivities with lectins known as binders to oligo-mannose, fucose, or galactose. Our findings along with previously reported monosaccharide components suggest that the polysaccharide can be cross-reactive with cell surface receptors involved in immune system, thereby exerting anti-influenza activity.


Asunto(s)
Antivirales/metabolismo , Lectinas/metabolismo , Polisacáridos/metabolismo , Análisis por Matrices de Proteínas , Sasa/química
9.
Biochem Biophys Res Commun ; 471(2): 328-33, 2016 Mar 04.
Artículo en Inglés | MEDLINE | ID: mdl-26874277

RESUMEN

It has been known that the phosphoSer/Thr-Pro-specific peptidyl prolyl cis/trans isomerase Pin1 regulates a variety of intracellular signaling pathways, including the response to the genotoxic drug doxorubicin. Pin1 binds phosphorylated p53 and stabilizes p53 to cause cell cycle arrest and apoptosis quickly in response to doxorubicin. Here we show another mechanism of Pin1 to maintain cell sensitivity to genotoxic stress, irrespective of whether p53 is present or not. In response to the genotoxic drug, Pin1 binds and decreases levels of the phosphorylated Foxo3, the positive transcription factor of P-glycoprotein (P-gp) gene. Through this mechanism of action, Pin1 decreases the level of P-gp and signals the cell to pump the genotoxic drugs out. This shows that Pin1 is implemented in maintaining the susceptibility to the genotoxic drugs by controlling P-gp level as well as p53-dependent apoptosis and cell cycle signaling pathways.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Doxorrubicina/administración & dosificación , Factores de Transcripción Forkhead/metabolismo , Isomerasa de Peptidilprolil/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Antibióticos Antineoplásicos/administración & dosificación , Relación Dosis-Respuesta a Droga , Proteína Forkhead Box O3 , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Células MCF-7 , Peptidilprolil Isomerasa de Interacción con NIMA
10.
Biochem Biophys Res Commun ; 433(1): 102-7, 2013 Mar 29.
Artículo en Inglés | MEDLINE | ID: mdl-23485459

RESUMEN

Retinoic acid (RA) signaling is mediated by specific nuclear hormone receptors. Here we examined the effects of 9-cis-RA on adipogenesis in mouse preadipocyte 3T3-L1 cells. 9-cis-RA inhibits the lipid accumulation of adipogenetically induced 3T3-L1 cells. The complex of retinoid X receptor α (RXRα) with peroxisome proliferator-activated receptor γ (PPARγ) is a major transcription factor in the process of adipogenesis, and the levels of these molecules were decreased by 9-cis-RA treatment. A RXR pan-antagonist suppressed 9-cis-RA's inhibitory effects on adipogenesis, but not on the intracellular levels of both RXRα and PPARγ. These results suggest that 9-cis-RA could inhibit adipogenesis by activating RXR, and decrease both RXR and PPARγs levels in a RXR activation-independent manner.


Asunto(s)
Adipogénesis/efectos de los fármacos , Adipogénesis/fisiología , Tretinoina/farmacología , Células 3T3-L1 , Alitretinoína , Animales , Dibenzazepinas/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Ratones , PPAR gamma/antagonistas & inhibidores , PPAR gamma/metabolismo , Receptores de Ácido Retinoico/antagonistas & inhibidores , Receptores de Ácido Retinoico/metabolismo , Receptor alfa X Retinoide/antagonistas & inhibidores , Receptor alfa X Retinoide/metabolismo
11.
PLoS One ; 18(2): e0276838, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36791055

RESUMEN

A cyclin-dependent kinase (CDK) inhibitor, p57Kip2, is an important molecule involved in bone development; p57Kip2-deficient (p57-/-) mice display neonatal lethality resulting from abnormal bone formation and cleft palate. The modulator 1α,25-dihydroxyvitamin D3 (l,25-(OH)2VD3) has shown the potential to suppress the proliferation and induce the differentiation of normal and tumor cells. The current study assessed the role of p57Kip2 in the 1,25-(OH)2VD3-regulated differentiation of osteoblasts because p57Kip2 is associated with the vitamin D receptor (VDR). Additionally, 1,25-(OH)2VD3 treatment increased p57KIP2 expression and induced the colocalization of p57KIP2 with VDR in the osteoblast nucleus. Primary p57-/- osteoblasts exhibited higher proliferation rates with Cdk activation than p57+/+ cells. A lower level of nodule mineralization was observed in p57-/- osteoblasts than in p57+/+ cells. In p57+/+ osteoblasts, 1,25-(OH)2VD3 upregulated the p57Kip2 and opn mRNA expression levels, while the opn expression levels were significantly decreased in p57-/- cells. The osteoclastogenesis assay performed using bone marrow cocultured with 1,25-(OH)2VD3-treated osteoblasts revealed a decreased efficiency of 1,25-(OH)2VD3-stimulated osteoclastogenesis in p57-/- cells. Based on these results, p57Kip2 might function as a mediator of 1,25-(OH)2VD3 signaling, thereby enabling sufficient VDR activation for osteoblast maturation.


Asunto(s)
Receptores de Calcitriol , Vitamina D , Animales , Ratones , Diferenciación Celular , Núcleo Celular/metabolismo , Inhibidor p57 de las Quinasas Dependientes de la Ciclina/genética , Inhibidor p57 de las Quinasas Dependientes de la Ciclina/metabolismo , Osteoblastos/metabolismo , Receptores de Calcitriol/genética , Receptores de Calcitriol/metabolismo , Vitamina D/metabolismo
12.
Biochem Biophys Res Commun ; 422(1): 133-8, 2012 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-22564744

RESUMEN

We studied the effects of Pin1, a regulatory molecule of the oncosuppressor p53, on both cell cycle arrest and apoptosis by treating primary mouse embryonic fibroblasts (MEFs) with etoposide. Etoposide induced G1 arrest in both wild-type and Pin1 null (pin1(-/-)) MEFs, and G2/M arrest and apoptotic cell death in MEFs lacking either p53 only (p53(-/-)) or both Pin1 and p53 (pin1(-/-)p53(-/-)). Both pin1(-/-) and pin1(-/-)p53(-/-) MEFs were enhanced the release of cytochrome c from the mitochondria, which might induce apoptosis. In response to etoposide treatment, apoptotic cell death was displayed in pin1(-/-)p53(-/-) MEFs but not in pin1(-/-) MEFs. These results suggest that p53 retards growth and suppresses etoposide-induced apoptosis in pin1(-/-) MEFs.


Asunto(s)
Apoptosis/fisiología , Proliferación Celular , Isomerasa de Peptidilprolil/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Células Cultivadas , Embrión de Mamíferos/citología , Etopósido/farmacología , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/fisiología , Puntos de Control de la Fase G1 del Ciclo Celular , Ratones , Mitocondrias/metabolismo , Peptidilprolil Isomerasa de Interacción con NIMA , Isomerasa de Peptidilprolil/genética , Permeabilidad , Fosforilación , Proteína p53 Supresora de Tumor/genética
13.
Placenta ; 104: 168-178, 2021 01 15.
Artículo en Inglés | MEDLINE | ID: mdl-33360007

RESUMEN

INTRODUCTION: Syncytiotrophoblasts are the major components of the human placenta involved in fetal maternal exchange and hormone secretion. The syncytiotrophoblasts arise from the fusion of villous cytotrophoblasts. The cell cycle suppressor p57KIP2 is known to be an essential molecule for proper trophoblast differentiation during placental formation. METHODS: We generated p57KIP2-expressing BeWo transfectant cells. Proliferation assay and matrigel invasion assay were used to characterize p57KIP2-expressing BeWo transfectant cells. To reveal the role of p57KIP2 in syncytialization, we proceeded syncytium formation analysis and qRT-PCR for detection of the expression levels Syncytin-1, Syncytin-2 and their receptors. RESULTS: The human choriocarcinoma cell line, BeWo has undetectable levels of p57KIP2 expression. Expression of p57KIP2 reduced cell proliferation rate and extracellular matrix invasion activity. p57KIP2 expressing cells displayed multinucleated cells associated with syncytiotrophoblast differentiation. In the syncytialization event, p57KIP2 was found to potentiate forskolin-induced upregulation of Syncytin-2 in a cAMP-independent manner. DISCUSSION: These results indicate that the expression of p57KIP2 may act on the proliferation/invasion inhibitory factor and enhance the expression of Syncytin-2, which are associated with syncytialization in cytotrophoblasts.


Asunto(s)
Proliferación Celular/fisiología , Inhibidor p57 de las Quinasas Dependientes de la Ciclina/metabolismo , Placenta/metabolismo , Trofoblastos/metabolismo , Diferenciación Celular/fisiología , Línea Celular Tumoral , Inhibidor p57 de las Quinasas Dependientes de la Ciclina/genética , Femenino , Humanos , Placenta/patología , Embarazo
14.
J Lipid Res ; 51(9): 2571-80, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20529882

RESUMEN

Cellular lipid droplets (LD) are organelles involved in cellular lipid metabolism. When liver cellular components were fractionated using sucrose density gradient centrifugation, adipose differentiation-related protein (ADRP) was distributed in both the top and bottom fractions, which correspond to the LD and membranous fractions, respectively, in the mouse liver under normal feeding conditions. After overnight fasting, triacylglycerol and ADRP increased nearly 2.5-fold in the mouse liver, and a portion appeared in the intermediate-density LD (iLD) fractions. ADRP in the iLD fractions was also increased in a mouse nonalcoholic steatohepatitis model induced by methione/choline-deficient diet. When HuH-7 human hepatoma cells were incubated with oleic acid for 24 h, the amount of ADRP increased, and it was distributed in both the LD and membrane fractions. However, ADRP appeared in the iLD fractions upon treatment of HuH-7 cells with glucagon. This behavior of ADRP was cAMP-dependent, as the ADRP-positive iLD fractions were induced by dibutylyl cAMP and were blocked by protein kinase A inhibitors. A portion of ADRP colocalized microscopically with calnexin, which is present in the iLD fractions, by treatment of HuH-7 cells or human primary hepatocytes with oleic acid and glucagon, but not by treatment with oleic acid alone. Glucagon has a role in the reorganization of endoplasmic reticulum membranes to generate ADRP-associated lipid-poor particles in hepatic cells, which is related to LD formation during lipid storage.


Asunto(s)
Glucagón/metabolismo , Hígado/metabolismo , Proteínas de la Membrana/metabolismo , Triglicéridos/metabolismo , Animales , Línea Celular , Hepatocitos/citología , Hepatocitos/metabolismo , Humanos , Metabolismo de los Lípidos/fisiología , Hígado/citología , Masculino , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Perilipina-2 , Transducción de Señal/fisiología
15.
Arterioscler Thromb Vasc Biol ; 29(1): 33-9, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18988894

RESUMEN

BACKGROUND: Plasma level of oxidized low-density lipoprotein (OxLDL) is a risk marker for cardiovascular diseases. The behavior of plasma OxLDL before disease progression has not been studied previously. METHODS AND RESULTS: In this study, we developed a sensitive ELISA procedure for detecting mouse circulating OxLDL using a monoclonal antibody that recognizes oxidized phosphatidylcholine and a rabbit antimouse apolipoprotein B-48 polyclonal antibody. Apolipoprotein E knockout mice were fed on a chow diet for 40 weeks. Oil red O-positive lesions developed gradually by 20 weeks, and the percentage area covered by the lesions increased dramatically after 28 weeks; it covers 33.4% of the surface area by 40 weeks. The OxLDL level, measured after LDL fraction was isolated from each mouse, at 10 weeks was 0.015 ng/microg LDL. It increased 3-fold at 20 weeks of age and then decreased to the basal level by 40 weeks of age, suggesting that OxLDL appears before the development of atherosclerotic lesions. The occurrence of lipid peroxidation products, acrolein and oxidized phosphatidylcholines, in aortic tissue were revealed by immunohistochemical staining as early as 10 weeks. CONCLUSIONS: These results suggest that OxLDL might be involved in the early stages of progression of atherosclerotic lesions.


Asunto(s)
Apolipoproteínas E/deficiencia , Aterosclerosis/fisiopatología , Lipoproteínas LDL/sangre , Anciano , Animales , Aorta Torácica/citología , Aorta Torácica/patología , Aterosclerosis/sangre , Aterosclerosis/patología , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Ensayo de Inmunoadsorción Enzimática , Humanos , Ratones , Ratones Noqueados , Persona de Mediana Edad , Especificidad de la Especie
16.
Adv Exp Med Biol ; 658: 111-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19950021

RESUMEN

Apopotosis of osteoclasts is regulated by the Bcl-2 family protein Bim. Bim is degraded in the course of osteoclast apoptosis, which is regulated by Caspase-3. Osteoclasts generated from caspase-3 -/- mice exhibited a shorter life span and a higher bone-resorbing activity than those generated from normal littermates. These results suggest the important role of Caspase-3-Bim axis in regulating both apoptosis and activation of osteoclasts.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/metabolismo , Apoptosis , Caspasa 3/metabolismo , Proteínas de la Membrana/metabolismo , Osteoclastos/citología , Osteoclastos/enzimología , Proteínas Proto-Oncogénicas/metabolismo , Animales , Proteína 11 Similar a Bcl2 , Caspasa 3/deficiencia , Supervivencia Celular , Regulación hacia Abajo , Embrión de Mamíferos/citología , Fibroblastos/metabolismo , Ratones , Modelos Biológicos
17.
Reprod Med Biol ; 9(2): 83-89, 2010 06.
Artículo en Inglés | MEDLINE | ID: mdl-29662425

RESUMEN

Purpose: The aim of this study is to determine the optimal culture period for meiotic maturation and developmental competence of in vitro-grown mouse oocytes. Methods: Early preantral follicles with diameter of 100-130 µm were collected mechanically from day 14 mouse ovaries and cultured for 8, 10, and 12 days. The diameters of follicles and oocytes were measured, and chromatin configuration in oocytes was observed. We also examined meiotic maturation by human chorionic gonadotropin (hCG)/epidermal growth factor (EGF) stimulation, developmental competence of fertilized oocytes to blastocysts, and apoptosis in blastocysts. Results: The follicular diameter increased significantly from days 4 to 10, and the diameter of day 12 oocytes was significantly larger than day 8 or earlier oocytes. Chromatin configuration around the nucleolus was transformed from "nonsurrounded (immature)" to "surrounded (mature)" after 10 days. Furthermore, MII rate of day 10 and 12 oocytes was significantly higher than that of day 8 oocytes. The blastocyst rate of day 10 oocytes was higher than that of day 8 or 12 oocytes. The blastocyst apoptotic rate of day 12 oocytes was higher than that of day 10 oocytes. Conclusions: Long culture periods of in vitro-grown oocytes affect meiotic maturation, developmental competence to blastocysts, and apoptosis.

19.
J Bone Miner Res ; 22(10): 1631-9, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17592965

RESUMEN

UNLABELLED: Proapoptotic Bcl-2 family member Bim plays an essential role in the osteoclast apoptosis and is degraded through ubiquitin/proteasome pathways in a caspase-3-dependent manner. This negative feedback loop in the Bim-caspase-3 axis is important for regulating the survival and activity of osteoclasts. INTRODUCTION: Bim is a member of the proapoptotic Bcl-2 family and regulates the mitochondrial apoptosis pathway. Bim expression is post-translationally regulated in osteoclasts (OCs) through ubiquitin/proteasome pathways, and Bim is critical for their survival and activity. MATERIALS AND METHODS: Time-course of change in the expression of Bim in the course of OC apoptosis was examined, and the effect of various proteinase inhibitors on the degradation of Bim was analyzed. The role of caspase-3 and caspase-7 on Bim degradation was studied using RNA interference technique and caspase-3(-/-) mice. RESULTS: Bim was degraded after caspase-3 activation, which was suppressed by a caspase inhibitor and a proteasome inhibitor. Bim degradation was suppressed by gene knockdown of caspase-3 or in caspase-3(-/-) OCs but not by caspase-7 knockdown. OCs generated from caspase-3(-/-) bone marrow cells exhibited a shorter life span and higher bone-resorbing activity than normal OCs. Association of Bim with E3 ubiquitin ligase c-Cbl was suppressed by gene knockdown of caspase-3 or in caspase-3(-/-) OCs. Actin ring formation and cathepsin K expression were promoted in caspase-3(-/-) OCs. CONCLUSIONS: Caspase-3 negatively regulates Bim expression by stimulating its degradation through ubiquitin/proteasome pathways, thus creating a negative feedback loop in the Bim-caspase axis.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/metabolismo , Apoptosis , Caspasa 3/metabolismo , Regulación hacia Abajo , Proteínas de la Membrana/metabolismo , Osteoclastos/citología , Osteoclastos/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Animales , Proteínas Reguladoras de la Apoptosis/genética , Proteína 11 Similar a Bcl2 , Caspasa 3/deficiencia , Caspasa 3/genética , Caspasa 7/genética , Caspasa 7/metabolismo , Línea Celular , Activación Enzimática , Retroalimentación Fisiológica , Proteínas de la Membrana/genética , Ratones , Ratones Noqueados , Osteoclastos/enzimología , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-cbl/metabolismo
20.
Biochim Biophys Acta ; 1761(7): 709-16, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16815093

RESUMEN

Adiponectin is an adipose tissue-specific secretory protein known to be an insulin-sensitizing protein. In this study, we generated adiponectin sense and antisense transgenic (Tg) mice to investigate whether adiponectin plays a role in the regulation of energy homeostasis during the growth stage. Spontaneous motor activity of antisense Tg mice were markedly reduced during fasting, particularly in young female mice, compared with wild type (Wt) and sense Tg mice. Furthermore, both body weight and adipose tissue mass of the antisense female Tg mice drastically reduced during fasting. To examine the relationship between the collapse of abdominal white adipose tissue (WAT) and serum adiponectin level, we measured the expression of genes related to energy expenditure, such as uncoupling protein (UCP). Notably, the mRNA of UCP1 in the WAT of antisense Tg female mice was markedly less than that of Wt mice and the UCP1 mRNA was strongly increased during fasting. These findings suggest that the serum adiponectin is important to maintaining energy homeostasis under energy shortage conditions, such as over female pubertal development.


Asunto(s)
Adiponectina/metabolismo , Metabolismo Energético , Adiponectina/genética , Tejido Adiposo/metabolismo , Envejecimiento/fisiología , Animales , Peso Corporal , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , ADN sin Sentido , Metabolismo Energético/genética , Ayuno , Femenino , Regulación del Desarrollo de la Expresión Génica , Canales Iónicos , Masculino , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Proteínas de Transporte de Membrana/genética , Proteínas de Transporte de Membrana/metabolismo , Ratones , Ratones Transgénicos , Proteínas Mitocondriales/genética , Proteínas Mitocondriales/metabolismo , Especificidad de Órganos , Factores Sexuales , Proteína Desacopladora 1 , Proteína Desacopladora 2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA